Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypes.

Van Cauwenberghe C, Bettens K, Engelborghs S, Vandenbulcke M, Van Dongen J, Vermeulen S, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K.

Neurobiol Aging. 2013 Sep;34(9):2235.e1-6. doi: 10.1016/j.neurobiolaging.2013.03.008. Epub 2013 Apr 10.

PMID:
23582656
2.

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.

Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert JC, Bettens K, Le Bastard N, Pasquier F, Montoya AG, Peeters K, Mattheijssens M, Vandenberghe R, Deyn PP, Cruts M, Amouyel P, Sleegers K, Van Broeckhoven C.

Mol Psychiatry. 2012 Feb;17(2):223-33. doi: 10.1038/mp.2011.24. Epub 2011 Mar 15.

3.

Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.

Zhang Q, Yu JT, Zhu QX, Zhang W, Wu ZC, Miao D, Tan L.

Brain Res. 2010 Aug 12;1348:216-21. doi: 10.1016/j.brainres.2010.06.018. Epub 2010 Jun 15.

PMID:
20558149
4.

A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline.

Keenan BT, Shulman JM, Chibnik LB, Raj T, Tran D, Sabuncu MR; Alzheimer's Disease Neuroimaging Initiative, Allen AN, Corneveaux JJ, Hardy JA, Huentelman MJ, Lemere CA, Myers AJ, Nicholson-Weller A, Reiman EM, Evans DA, Bennett DA, De Jager PL.

Hum Mol Genet. 2012 May 15;21(10):2377-88. doi: 10.1093/hmg/dds054. Epub 2012 Feb 17.

5.

Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.

Pedraza O, Allen M, Jennette K, Carrasquillo M, Crook J, Serie D, Pankratz VS, Palusak R, Nguyen T, Malphrus K, Ma L, Bisceglio G, Roberts RO, Lucas JA, Ivnik RJ, Smith GE, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Alzheimers Dement. 2014 Mar;10(2):205-13. doi: 10.1016/j.jalz.2013.01.016. Epub 2013 May 2.

6.

Alzheimer's disease risk factor complement receptor 1 is associated with depression.

Hamilton G, Evans KL, Macintyre DJ, Deary IJ, Dominiczak A, Smith BH, Morris AD, Porteous DJ, Thomson PA.

Neurosci Lett. 2012 Feb 21;510(1):6-9. doi: 10.1016/j.neulet.2011.12.059. Epub 2012 Jan 8.

PMID:
22244847
7.

Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease.

Antúnez C, Boada M, López-Arrieta J, Moreno-Rey C, Hernández I, Marín J, Gayán J; Alzheimer's Disease Neuroimaging Initiative, González-Pérez A, Real LM, Alegret M, Tárraga L, Ramírez-Lorca R, Ruiz A.

Alzheimers Dement. 2011 Jul;7(4):e124-9. doi: 10.1016/j.jalz.2011.05.2412.

PMID:
21784344
8.

Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function.

Fonseca MI, Chu S, Pierce AL, Brubaker WD, Hauhart RE, Mastroeni D, Clarke EV, Rogers J, Atkinson JP, Tenner AJ.

PLoS One. 2016 Feb 25;11(2):e0149792. doi: 10.1371/journal.pone.0149792. eCollection 2016.

9.

Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: a meta-analysis.

Jin C, Li W, Yuan J, Xu W, Cheng Z.

Neurosci Lett. 2012 Oct 3;527(1):46-9. doi: 10.1016/j.neulet.2012.08.032. Epub 2012 Aug 27.

PMID:
22960360
10.

Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism.

Hazrati LN, Van Cauwenberghe C, Brooks PL, Brouwers N, Ghani M, Sato C, Cruts M, Sleegers K, St George-Hyslop P, Van Broeckhoven C, Rogaeva E.

Neurobiol Aging. 2012 Dec;33(12):2949.e5-2949.e12. doi: 10.1016/j.neurobiolaging.2012.07.001. Epub 2012 Jul 21.

PMID:
22819390
11.

Implication of common and disease specific variants in CLU, CR1, and PICALM.

Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC, Momeni P.

Neurobiol Aging. 2012 Aug;33(8):1846.e7-18. doi: 10.1016/j.neurobiolaging.2012.01.110. Epub 2012 Mar 7.

PMID:
22402018
12.

Alzheimer's disease is associated with low density of the long CR1 isoform.

Mahmoudi R, Kisserli A, Novella JL, Donvito B, Dramé M, Réveil B, Duret V, Jolly D, Pham BN, Cohen JH.

Neurobiol Aging. 2015 Apr;36(4):1766.e5-12. doi: 10.1016/j.neurobiolaging.2015.01.006. Epub 2015 Jan 9.

PMID:
25666996
13.

Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population.

Omoumi A, Fok A, Greenwood T, Sadovnick AD, Feldman HH, Hsiung GY.

Neurobiol Aging. 2014 Apr;35(4):936.e5-12. doi: 10.1016/j.neurobiolaging.2013.09.025. Epub 2013 Oct 28.

PMID:
24176626
14.

CR1 is associated with amyloid plaque burden and age-related cognitive decline.

Chibnik LB, Shulman JM, Leurgans SE, Schneider JA, Wilson RS, Tran D, Aubin C, Buchman AS, Heward CB, Myers AJ, Hardy JA, Huentelman MJ, Corneveaux JJ, Reiman EM, Evans DA, Bennett DA, De Jager PL.

Ann Neurol. 2011 Mar;69(3):560-9. doi: 10.1002/ana.22277. Epub 2011 Mar 9.

15.

An Updated Analysis with 85,939 Samples Confirms the Association Between CR1 rs6656401 Polymorphism and Alzheimer's Disease.

Shen N, Chen B, Jiang Y, Feng R, Liao M, Zhang L, Li F, Ma G, Chen Z, Zhao B, Li K, Liu G.

Mol Neurobiol. 2015;51(3):1017-23. doi: 10.1007/s12035-014-8761-2. Epub 2014 May 31.

PMID:
24878768
16.

Meta-analysis of the association between CR1 polymorphisms and risk of late-onset Alzheimer's disease.

Luo J, Li S, Qin X, Song L, Peng Q, Chen S, Xie Y, Xie L, Li T, He Y, Deng Y, Wang J, Zeng Z.

Neurosci Lett. 2014 Aug 22;578:165-70. doi: 10.1016/j.neulet.2014.06.055. Epub 2014 Jul 1.

PMID:
24996192
17.

Genetic variation at CR1 increases risk of cerebral amyloid angiopathy.

Biffi A, Shulman JM, Jagiella JM, Cortellini L, Ayres AM, Schwab K, Brown DL, Silliman SL, Selim M, Worrall BB, Meschia JF, Slowik A, De Jager PL, Greenberg SM, Schneider JA, Bennett DA, Rosand J.

Neurology. 2012 Jan 31;78(5):334-41. doi: 10.1212/WNL.0b013e3182452b40. Epub 2012 Jan 18.

18.

Allele-specific polymerase chain reaction for the detection of Alzheimer's disease-related single nucleotide polymorphisms.

Darawi MN, Ai-Vyrn C, Ramasamy K, Hua PP, Pin TM, Kamaruzzaman SB, Majeed AB.

BMC Med Genet. 2013 Feb 19;14:27. doi: 10.1186/1471-2350-14-27.

19.

Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population.

Klimkowicz-Mrowiec A, Sado M, Dziubek A, Dziedzic T, Pera J, Szczudlik A, Slowik A.

Neurol Neurochir Pol. 2013 Mar-Apr;47(2):157-60.

PMID:
23650005
20.

A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk.

Chapman J, Rees E, Harold D, Ivanov D, Gerrish A, Sims R, Hollingworth P, Stretton A; GERAD1 Consortium, Holmans P, Owen MJ, O'Donovan MC, Williams J, Kirov G.

Hum Mol Genet. 2013 Feb 15;22(4):816-24. doi: 10.1093/hmg/dds476. Epub 2012 Nov 11.

Supplemental Content

Support Center